Showing 1,401 - 1,420 results of 2,530 for search '"Vaccine"', query time: 0.07s Refine Results
  1. 1401

    Analysis of whole genome sequence of strain "0" of avian infectious laryngotracheitis virus by A. A. Kozlov, N. G. Zinyakov, S. N. Kolosov, N. S. Mudrak, I. A. Chvala

    Published 2018-04-01
    “…It is the first complete genetic characterization of the domestic vaccine strain.…”
    Get full text
    Article
  2. 1402

    Questions from the fourth son: A clinician reflects on immunomonitoring, surrogate markers and systems biology by Charles Wiseman, M.D.

    Published 2011-03-01
    “…Unlike prophylactic vaccines for infectious disease, where the development of antibody is considered a satisfactory endpoint, no such endpoint exists for human therapeutic vaccines. …”
    Get full text
    Article
  3. 1403

    A Mathematical Model For The Dynamics of Polio. by Owobusingye, Johnan

    Published 2024
    “…There is a lack of treatment for poliomyelitis and it is only prevented through immunization with live oral polio vaccine (OPV) or/and inactivated polio vaccine (IPV). …”
    Get full text
    Thesis
  4. 1404
  5. 1405

    RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2 by Rang Feng, Ruo-Yi Xue, Chang Liu, Guo-Cheng Li, Yan Deng, Zhe Jin, Jing-Yi Liu, Shan-Shan Zhang, Hao Cheng, Man-Ying Guo, Quan-Ming Zou, Hai-Bo Li

    Published 2025-02-01
    “…Importantly, the induced antibodies effectively inhibited the binding of RBD to human angiotensin-converting enzyme 2 (hACE2) and neutralized SARS-CoV-2 pseudoviruses. Conclusions This vaccine platform offers an alternative strategy for developing recombinant subunit vaccines against SARS-CoV-2, potentially enhancing immune responses and improving vaccine efficacy. …”
    Get full text
    Article
  6. 1406
  7. 1407

    Economic impact of cholera in households in rural southern Malawi: a prospective study by Florian Marks, Wilm Quentin, Vittal Mogasale, Amber Hsiao, Enusa Ramani, Hye-Jin Seo, GiDeok Pak, Dan Vuntade, Maurice M’bang’ombe, Bagrey Ngwira

    Published 2022-06-01
    “…The present study estimated the COI of cholera in Nsanje, southern Malawi, as part of the Cholera Surveillance in Malawi (CSIMA) programme following a mass cholera vaccination campaign in 2015.Methods Patients ≥12 months of age who were recruited as part of CSIMA were invited to participate in the COI survey. …”
    Get full text
    Article
  8. 1408

    Naturally Acquired Antibody Responses to a Synthetic Malaria Antigen AS202.11 by Rebeka Nazareth, Pius Horumpende, Tolbert Sonda, Arnold Ndaro, Edson Mollel, Eliakim Paul, Emmanuel Athanase, Jaffu Chilongola

    Published 2017-01-01
    “…A major challenge to malaria vaccine development is identification of protective epitopes and respective protective immune responses. …”
    Get full text
    Article
  9. 1409

    Multiplex Evaluation of Influenza Neutralizing Antibodies with Potential Applicability to In-Field Serological Studies by Eleonora Molesti, Edward Wright, Calogero Terregino, Rafat Rahman, Giovanni Cattoli, Nigel J. Temperton

    Published 2014-01-01
    “…Sera obtained from chickens vaccinated with a monovalent H5N2 vaccine, chickens vaccinated with a bivalent H7N1/H5N9 vaccine, or turkeys naturally infected with an H7N3 virus were evaluated in this assay and the results correlated strongly with data obtained by HI assay. …”
    Get full text
    Article
  10. 1410

    Indirect determination of FMDV 146S component concentration in non-inactivated suspension by comparison of graphs of the second derivative for real-time RT-PCR curves by M. I. Doronin, D. V. Mikhalishin, V. A. Starikov, D. A. Lozovoy, A. V. Borisov

    Published 2020-09-01
    “…In the process of industrial production of FMD vaccines, special attention is paid to the number of whole virions, which have the most important biological properties of FMD virus and are the main components that determine the immunogenicity of vaccine preparations. …”
    Get full text
    Article
  11. 1411

    Determination of indicators for tests of polysept (polyhexamethylene guanidine hydrochloride) for flocculation properties by M. N. Guseva, M. I. Doronin, M. A. Shevchenko, D. V. Mikhalishin, Y. M. Gochmuradov, V. V. Mikhalishin, Y. S. El’kina

    Published 2022-09-01
    “…In vaccine production, it is particularly important to purify the virus-containing suspension in order to remove ballast proteins and fats, which, when present in high concentrations, are responsible for depression or allergic reactions in animals. …”
    Get full text
    Article
  12. 1412
  13. 1413

    Perbedaan Kadar Interferon Gamma dan Interleukin-10 pada Orang Dewasa Terinfeksi Ascaris Lumbricoides dengan Tidak Terinfeksi yang Diinduksi Vaksin Bacille Calmette-Guerin by weni Mulyani, Nuzulia Irawati, Netti Suharti

    Published 2015-09-01
    “…It can be concluded that Ascaris lumbricoides infection can pressure IFN-y production on given BCG vaccine. </p><p>Keywords: ascaris lumbricoides, BCG vaccine, interferon gamma (IFN-γ), Interleukin 10 (IL-10)<br /><br /><br /><br /></p>…”
    Get full text
    Article
  14. 1414

    The Impact of Media Coverage and Curfew on the Outbreak of Coronavirus Disease 2019 Model: Stability and Bifurcation by Afrah K. S. Al-Tameemi, Raid K. Naji

    Published 2021-01-01
    “…In fact, to stop the spread of COVID-19, the vaccine of the disease is needed. However, in the absence of the vaccine, people must have to obey curfew and social distancing and follow the media alert coverage rule. …”
    Get full text
    Article
  15. 1415

    Clinical and economic burden of varicella in pediatric patients hospitalized in four institutions in Guatemala. by Mario Melgar, Ingrid Sajmolo, André Chocó, Lidia Ortiz, Ana Gabriela Cordova, Luis Hernández, Irwing Rivera, Ashly Zuñiga, Claudia Beltrán, Sebastian Medina, Marcel Marcano-Lozada

    Published 2025-01-01
    “…Varicella presents a public health challenge in Guatemala, with limited evidence regarding its impact; vaccine is currently absent from the national immunization program. …”
    Get full text
    Article
  16. 1416
  17. 1417

    Balancing mitigation strategies for viral outbreaks by Hamed Karami, Pejman Sanaei, Alexandra Smirnova

    Published 2024-12-01
    “…This paper examined biological models for the post-vaccination stage of a viral outbreak that integrate two important mitigation tools: social distancing, aimed at reducing the disease transmission rate, and vaccination, which boosts the immune system. …”
    Get full text
    Article
  18. 1418

    Combination Immunotherapy with 4-1BBL and CTLA-4 Blockade for the Treatment of Prostate Cancer by Kuang Youlin, Zhang Li, Weng Xiaodong, Liu Xiuheng, Zhu Hengchen

    Published 2012-01-01
    “…In this study, we examined the effectiveness of 4-1BBL-expressing tumor cell vaccine in combination with CTLA-4 blockade on rejection of murine prostate cancer RM-1. …”
    Get full text
    Article
  19. 1419

    What Is the Optimal Geometry of Dissolving Microneedle Arrays? A Literature Review by Maira Visscher, Henderik W. Frijlink, Wouter L. J. Hinrichs

    Published 2025-01-01
    “…The application of dissolving microneedle arrays (DMNAs) is an emerging trend in drug and vaccine delivery as an alternative for hypodermic needles or other less convenient drug administration methods. …”
    Get full text
    Article
  20. 1420